ADD/ADHD



Neuroplasticity Technology for Attention-deficit/Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Behavioral: Adaptive Inhibitory Control Training;   Behavioral: Non-adaptive Inhibitory Control Training
Sponsors:   Boston Children’s Hospital;   Neuroscouting, L.L.C.
Completed


Group Dialectical Behavior Therapy as add-on Treatment for Adults With Attention Deficit/Hyperactive Disorder


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Behavioral: Skill Training Group of the Dialectical Behavior Therapy;   Other: Treatment as Usual
Sponsor:   Hospital de Clinicas de Porto Alegre
Not yet recruiting


Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
Intervention:   Drug: SHP465
Sponsor:   Shire
Not yet recruiting


Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
Intervention:   Drug: SHP465
Sponsor:   Shire
Recruiting


Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years


Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
Interventions:   Drug: SHP465;   Drug: Placebo
Sponsor:   Shire
Recruiting


The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder


Condition:   Adult Attention Deficit Hyperactivity Disorder
Interventions:   Drug: OPC-64005;   Drug: Atomoxetine;   Drug: Placebo
Sponsor:   Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting


Effects of Polyunsaturated Fatty Acids on the Visual Memory of Children With Attention Deficit Hyperactivity Disorder


Condition:   Attention-deficit/Hyperactivity Disorder
Intervention:  
Sponsor:   National Taiwan University Hospital
Recruiting


Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
Interventions:   Drug: Placebo;   Drug: SPD489 (Lisdexamfetamine dimesylate);   Drug: SPD489
Sponsor:   Shire
Recruiting


A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.


Condition:   Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions:   Drug: dasotraline;   Drug: Placebo
Sponsor:   Sunovion
Recruiting


Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Methylphenidate LA (Ritalin);   Drug: Mixed Amphetamine Salts XR (Adderall)
Sponsors:   Massachusetts General Hospital;   Massachusetts Institute of Technology
Not yet recruiting


Cognitive Behavior Group Therapy in Adolescents With Attention Deficit Hyperactivity Disorder


Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Behavioral: cognitive behavior group therapy;   Other: Treatment as usual
Sponsors:   St. Olavs Hospital;   Norwegian University of Science and Technology
Recruiting


Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Behavioral: Cognitive-behavioral therapy
Sponsor:   Karolinska Institutet
Completed


Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Drug: mazindol
Sponsor:   NLS-1 Pharma Inc.
Completed


The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
Interventions:   Drug: Methylphenidate compounds and /or Amphetamine compounds and/or Strattera or Guanfacine;   Behavioral: Aerobic Exercise
Sponsor:   McGill University Health Center
Recruiting


Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder


Condition:   Attention Deficit-Hyperactivity Disorder
Interventions:   Device: Neurofeedback NFT;   Drug: Methylphenidate MPH
Sponsors:   Mensia Technologies SA;   European Union H2020 SME Instrument
Recruiting


Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Rhodiola;   Drug: Placebo
Sponsor:   Hospital de Clinicas de Porto Alegre
Recruiting


Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder


Condition:   Attention Deficit/Hyperactivity Disorder
Interventions:   Drug: Rhodiola;   Drug: Placebo
Sponsor:   Hospital de Clinicas de Porto Alegre
Recruiting


A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.


Condition:   Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions:   Drug: dasotraline 4mg;   Other: Placebo
Sponsor:   Sunovion
Completed


Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Behavioral: Cognitive Behavioural & Skills Training;   Behavioral: Supportive Group Therapy;   Other: Treatment as Usual - community resources;   Drug: Methylphenidate or amphetamine product
Sponsors:   McGill University Health Center;   Canadian Institutes of Health Research (CIHR)
Recruiting


Attention Deficit/Hyperactivity Disorder Internet Survey Study in a College Student Population


Condition:   Attention Deficit Hyperactivity Disorder
Intervention:  
Sponsor:   Wake Forest University Health Sciences
Completed


Role of Circadian and Homeostatic Systems in the Regulation of Wakefulness in Adult Patients With Attention Deficit Disorder With or Without Hyperactivity


Condition:   Attention-Deficit/Hyperactivity Disorder
Intervention:   Other: Neuropsychological tests
Sponsor:   University Hospital, Bordeaux
Completed


Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: methylphenidate or amphetamine product;   Behavioral: Cognitive behavioral therapy
Sponsor:   Lily Hechtman
Active, not recruiting


Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Behavioral: Neurofeedback;   Behavioral: Cognitive Training;   Other: Waitlist Control
Sponsor:   Tufts Medical Center
Completed


Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)


Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Ritalin;   Drug: Placebo
Sponsor:   McGill University
Recruiting


Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison


Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Strattera
Sponsor:   Norwegian University of Science and Technology
Completed

Refine Your Search Advanced Search